Showing 211-220 of 606 results for "".
Onabotulinumtoxin A for Headache: An Update
https://practicalneurology.com/diseases-diagnoses/headache-pain/onabotulinumtoxin-a-for-headache-an-update/30783/A year after FDA approval, a specialist offers an update on neurotoxin therapy for migraine and headache.Vasculitis Presenting as a Hypertensive Crisis With Back Pain
https://practicalneurology.com/diseases-diagnoses/stroke/vasculitis-presenting-as-a-hypertensive-crisis-with-back-pain/30203/Because laboratory and imaging studies may not be sensitive enough to detect central nervous system vasculitis, maintain a low threshold for further evaluation when clinical suspicion is high.Diagnosis and Management of Piriformis Syndrome
https://practicalneurology.com/diseases-diagnoses/neuromuscular/diagnosis-and-management-of-piriformis-syndrome/30772/Piriformis syndrome is a neuromuscular condition that remains poorly understood and often misdiagnosed.Case Report: Cyclophosphamide as Rescue Agent in Myasthenic Crisis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/case-report-cyclophosphamide-as-rescue-agent-in-myasthenic-crisis/30120/When patients are refractory to first-line treatments for myasthenic crisis, cyclophosphamide may have benefits and warrants further study.Dementia Insights: Blood Pressure Control and Cognitive Impairment
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-blood-pressure-control-and-cognitive-impairment/30151/Could recommendations for more aggressive blood pressure control worsen prognosis for vascular and neurodegenerative cognitive impairments?Onabotulinumtoxin in the Preventive Treatment of Chronic Migraine and Other Headaches
https://practicalneurology.com/diseases-diagnoses/headache-pain/onabotulinumtoxin-in-the-preventive-treatment-of-chronic-migraine-and-other-headaches/30833/While BoNTA shows promise in the management of chronic migraine, optimal outcomes will be acheived when clinicians learn which patients are most likely to benefit.Calcitonin Gene-Related Peptide, Monoclonal Antibodies, and Migraine
https://practicalneurology.com/diseases-diagnoses/headache-pain/calcitonin-gene-related-peptide-monoclonal-antibodies-and-migraine/30404/The recent development of monoclonal antibodies for the treatment of migraine may have a significant impact on the field and mark a new chapter in patient care.Migraine: Essentials of Patient Evaluation and Acute Treatment
https://practicalneurology.com/diseases-diagnoses/headache-pain/PN0209_01-php/30944/Clinicians who are knowledgeable of acute treatments, able to combine treatment modalities, and skilled at understanding patients' needs can successfully individualize treatment.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31019/Optimizing Restless Legs Syndrome Treatment: Insights from Recent Meta-Analysis and Clinical ExperiencesA recent meta-analysis evaluating the side effects and wearing-off effects of four Restless Legs Syndrome (RLS) medications highlighted significant findings relevant to clinical practice. The stud
- Second Opinionshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0505SecondOpinion-pdf/31458/Addressing the AD-VaD Diagnostic Challenge in NeurologyIn the debate surrounding Alzheimer’s Disease (AD) versus vascular dementia (VaD) diagnosis, Dr. Geldmacher’s April 2005 article, “Diagnosing Alzheimer’s: Easy Answers vs. Right Answers,” ignited significant discourse. Dr. Geldmacher critiques c